Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results. Appendix 5 of 5

25 Feb 2010 07:01

RNS Number : 6577H
Royal Bank of Scotland Group PLC
25 February 2010
 



 

 

 

 

 

 

 

 

 

 

Appendix 5

 

Annual results 2009

 

Revisions

 

 Appendix 5 - Revisions

 

Divisional revisions

Divisional results have been revised to reflect the transfer of RBS Sempra Commodities to Non-Core from GBM. These changes do not affect the Group's results.

 

Quarter ended 30 September 2009

Quarter ended 30 June 2009

 Previously 

 reported 

Adjustment 

Revised 

 Previously 

 reported 

Adjustment 

Revised 

Global Banking & Markets

£m 

£m 

£m 

 

£m 

£m 

£m 

Net interest income

447 

447 

660 

660 

Non-interest income

1,412 

(114)

1,298 

1,650 

(207)

1,443 

Direct expenses

- staff costs

(760)

39 

(721)

(762)

82 

(680)

- other costs

(261)

21 

(240)

(231)

27 

(204)

Impairment losses

(272)

(272)

31 

31 

Operating profit

375 

(54)

321 

1,147 

(98)

1,049 

£bn 

£bn 

£bn 

 

£bn 

£bn 

£bn 

Loans and advances (including banks)

157.0 

(0.7)

156.3 

156.0 

(0.8)

155.2 

Reverse repos

75.4 

75.4 

75.2 

75.2 

Securities

117.6 

117.6 

115.5 

115.5 

Cash and eligible bills

63.8 

63.8 

51.5 

51.5 

Other

50.8 

(4.8)

46.0 

46.2 

(5.7)

40.5 

Total third party assets (excluding

derivatives mark to market)

464.6 

(5.5)

459.1 

444.4 

(6.5)

437.9 

Customer deposits (excluding repos)

58.1 

(1.3)

56.8 

65.0 

(1.6)

63.4 

Risk-weighted assets

131.9 

(10.4)

121.5 

122.4 

(9.9)

112.5 

Quarter ended 31 March 2009

Quarter ended 31 December 2008

 Previously 

 reported 

Adjustment 

Revised 

 Previously 

 reported 

Adjustment 

Revised 

Global Banking & Markets

£m 

£m 

£m 

 

£m 

£m 

£m 

Net interest income

812 

812 

1,054 

1,054 

Non-interest income

4,527 

(247)

4,280 

(2,850)

(404)

(3,254)

Direct expenses

- staff costs

(1,001)

113 

(888)

(178)

160 

(18)

- other costs

(300)

26 

(274)

(421)

24 

(397)

Impairment losses

(269)

(269)

(505)

(502)

Operating profit/(loss)

3,576 

(108)

3,468 

(3,102)

(217)

(3,319)

 

 

 

 

 

 

 

Loans and advances (including banks)

206.5 

(1.2)

205.3 

225.5 

(1.3)

224.2 

Reverse repos

80.6 

80.6 

88.8 

88.8 

Securities

124.3 

124.3 

127.5 

127.5 

Cash and eligible bills

28.6 

28.6 

20.2 

20.2 

Other

43.1 

(5.7)

37.4 

42.9 

(4.9)

38.0 

Total third party assets (excluding

derivatives mark to market)

483.1 

(6.9)

476.2 

504.9 

(6.2)

498.7 

Customer deposits (excluding repos)

81.8 

(1.7)

80.1 

88.6 

(0.8)

87.8 

Risk-weighted assets

148.6 

(10.7)

137.9 

162.4 

(10.6)

151.8 

 

Appendix 5 - Revisions

 

Quarter ended 30 September 2009

Quarter ended 30 June 2009

 Previously 

 Reported

Adjustment 

Revised 

 Previously 

 reported 

Adjustment 

Revised 

Non-Core

£m 

£m 

£m 

£m 

£m 

£m 

Net interest income

287 

287 

274 

274 

Non-interest income

(347)

114 

(233)

(1,168)

207 

(961)

Direct expenses

- staff costs

(111)

(39)

(150)

(71)

(82)

(153)

- other costs

(223)

(21)

(244)

(220)

(27)

(247)

Impairment losses

(2,066)

(2,066)

(3,516)

(3,516)

Operating loss

(2,718)

54 

(2,664)

(4,975)

98 

(4,877)

£bn 

£bn 

£bn 

 

£bn 

£bn 

£bn 

Total third party assets (including

derivatives)

220.2 

12.8 

233.0 

231.9 

14.6 

246.5 

Loans and advances to customers - gross

158.7 

0.4 

159.1 

163.6 

0.5 

164.1 

Customer deposits

14.7 

1.3 

16.0 

13.4 

1.6 

15.0 

Risk-weighted assets

190.3 

10.4 

200.7 

164.1 

9.9 

174.0 

 

Quarter ended 31 March 2009

Quarter ended 31 December 2008

 Previously 

 reported 

Adjustment 

Revised 

 Previously 

 Reported

Adjustment 

Revised 

Non-Core

£m 

£m 

£m 

£m 

£m 

£m 

Net interest income

395 

395 

765 

765 

Non-interest income

(2,418)

247 

(2,171)

(3,099)

404 

(2,695)

Direct expenses

- staff costs

(188)

(113)

(301)

(110)

(160)

(270)

- other costs

(230)

(26)

(256)

(321)

(24)

(345)

Impairment losses

(1,828)

(1,828)

(3,358)

(3)

(3,361)

Operating loss

(4,588)

108 

(4,480)

(6,467)

217 

(6,250)

 

 

 

 

 

 

 

Total third party assets (including

derivatives)

297.1 

17.6 

314.7 

325.1 

17.8 

342.9 

Loans and advances to customers - gross

183.1 

0.6 

183.7 

190.6 

0.8 

191.4 

Customer deposits

21.9 

1.8 

23.7 

26.6 

0.8 

27.4 

Risk-weighted assets

163.7 

10.7 

174.4 

160.3 

10.6 

170.9 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR PGUUPPUPUUPA
Date   Source Headline
5th Nov 20184:21 pmRNSPublication of Suppl.Prospcts
2nd Nov 20185:25 pmRNSPublication of 2018 EBA EU-wide stress test result
2nd Nov 20182:10 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSUK intra-Group capital & liquidity arrangements
31st Oct 20182:38 pmRNSTotal Voting Rights
31st Oct 20187:00 amRNSDividend Declaration
30th Oct 20184:05 pmRNSDirector/PDMR Shareholding
29th Oct 20183:46 pmRNSDirector/PDMR Shareholding
26th Oct 20187:00 amRNSInterim Management Statement
9th Oct 20182:07 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:43 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20183:00 pmRNSDirector/PDMR Shareholding
28th Sep 201812:32 pmRNSTotal Voting Rights
25th Sep 201811:23 amRNSPricing of USD Fixed Rate to Floating Rate Notes
25th Sep 20187:00 amRNSBofAML Annual Financial CEO Conference
24th Sep 20189:00 amRNSRBS Investor SeminarUK Personal & Business Banking
17th Sep 201812:05 pmRNSPublication of Final Terms
13th Sep 201812:25 pmRNSForm 8.3 - CareTech Holdings
13th Sep 20188:00 amRNSBarclays Global Financial Services Conference
3rd Sep 20186:00 pmRNSPublication of Final Terms
31st Aug 20184:42 pmRNSTotal Voting Rights
31st Aug 20184:15 pmRNSNatWest Markets N.V. Interim Results 2018
22nd Aug 20185:01 pmRNSDividend Declaration
21st Aug 20183:32 pmRNSPublication of Suppl.Prospcts
17th Aug 20187:00 amRNSDirectorate Change
15th Aug 20187:00 amRNSDeclaration of Interim Dividend
13th Aug 20189:00 amRNSUpdate on ring-fencing plans
3rd Aug 20182:25 pmRNSForm 8.3 - [CareTech Holdings]
3rd Aug 20187:00 amRNSHalf-year Report
31st Jul 20182:44 pmRNSUpdate on ring-fencing plans
31st Jul 201812:04 pmRNSTotal Voting Rights
26th Jul 201812:17 pmRNSForm 8.3 - CareTech Holdings PLC
23rd Jul 20182:10 pmRNSForm 8.3 - CareTech Holdings plc
17th Jul 201811:46 amRNSRBS welcomes credit ratings action by Moody's
16th Jul 20186:18 pmRNSAllotment and Issue of New Ordinary Shares
16th Jul 20184:18 pmRNSForm 8.3 - CareTech Holdings plc
2nd Jul 20182:47 pmRNSCapital reduction - notice of completion
29th Jun 201812:51 pmRNSTotal Voting Rights
27th Jun 20184:36 pmRNSHolding(s) in Company
25th Jun 201811:52 amRNSPublication of Final Terms
22nd Jun 20185:28 pmRNSPublication of Final Terms
21st Jun 201811:52 amRNSPricing of USD Dual-Tranche Notes
8th Jun 20189:23 amRNSTR-1 Notification of major shareholdings
7th Jun 20189:00 amRNSGoldman Sachs European Financials Conference
5th Jun 20187:00 amRNSDisposal of approximately 7.7% of RBS Group plc.
4th Jun 20184:36 pmRNSIntention to dispose of c7.7% of RBS Group plc.
31st May 20185:32 pmRNSTotal Voting Rights
31st May 20184:30 pmRNSRBS notes credit rating actions by Standard&Poor's
31st May 201812:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.